(Total Views: 604)
Posted On: 01/10/2022 3:05:17 PM
Post# of 154091
Re: Evil Rabbit #114543
Avg volume for RGMP for last 65 days was 77 shares and price was under one dollar.
Not happy to be the drug they use to build a capability.
Anne Kirby, Chief Executive Officer of Regnum Corp., noted: "This is an important step towards Regnum's evolution into a fully integrated biopharmaceutical company. Our partnership with CytoDyn aligns with our commitment to bringing novel therapies to patient populations in need of new treatment options or refined care plans."
Not good news
IMO
2:59
O
IVARAR
Regnum Corp.
RGMP (U.S: OTC)
2:30 PM EST 01/10/22
$ 15 USD 0.9988 660.58% A
DELAYED 15 MINUTES
1 M
$
%
$1.0
$0.5
$0.0
Jan 10
Dec 13
Volume
417,936
1 Day Range
0.2312-1.43
Dec 20
Dec 27
Jan 3
65 Day Avg Vol
77
52 Week Range
0.045-2.40
(01/29/21-04/09/21)
OVERVIEW
COMPANY INFO
600 Third Avenue
10th Floor
New York New York 10016
United States
Map
@wsj.com
Not happy to be the drug they use to build a capability.
Anne Kirby, Chief Executive Officer of Regnum Corp., noted: "This is an important step towards Regnum's evolution into a fully integrated biopharmaceutical company. Our partnership with CytoDyn aligns with our commitment to bringing novel therapies to patient populations in need of new treatment options or refined care plans."
Not good news
IMO
2:59
O
IVARAR
Regnum Corp.
RGMP (U.S: OTC)
2:30 PM EST 01/10/22
$ 15 USD 0.9988 660.58% A
DELAYED 15 MINUTES
1 M
$
%
$1.0
$0.5
$0.0
Jan 10
Dec 13
Volume
417,936
1 Day Range
0.2312-1.43
Dec 20
Dec 27
Jan 3
65 Day Avg Vol
77
52 Week Range
0.045-2.40
(01/29/21-04/09/21)
OVERVIEW
COMPANY INFO
600 Third Avenue
10th Floor
New York New York 10016
United States
Map
@wsj.com
(0)
(0)
